SCHEMBL8089488

SCHEMBL8089488

O=C(COCC(F)(F)F)c1ccc(OCS)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.43
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
MAPK1 P28482 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081324 0.80 NR4A2 (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7345341 0.79 PLOD2 (0.56) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL13606920 0.78 NPC1 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL4342386 0.77 ALDH1A1 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7334312 0.74 PDE4A (0.42) GRM4RAB9ASMN1; SMN2LMNAL3MBTL1
SCHEMBL1432939 0.72 MAOB (0.45) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL8095122 0.72 NPC1 (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27931867 0.71 RAB9A (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL9248136 0.70 NPC1 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL8088532 0.69 GSK3B (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6090805-A Tocolytic oxytocin receptor antagonists MERCK & CO., INC. (US) 2000-07-18 US disclosed